Avatar 1Avatar 2Avatar 3Avatar 4Avatar 5

Earn 10$ Cash for every Pro+ Friend you Refer!

Biomarin Pharmaceutical Inc

Biomarin Pharmaceutical Inc

BMRN · NASDAQ
BMRN · NASDAQ
55.51
USD-0.11-0.19%

Latest News

    Seeking Alpha

    Key deals this week: Trump Media & Technology, Howard Hughes, BioMarin Pharmaceutical and more

      SeekingAlpha

      BMO sees BMRN, LEGN, SLN as attractive M&A targets

        @DeItaone
        DeItaone

        Coverage Initiated $ALLO $ALNY $ARWR $BEAM $BMRN $CRSP $IONS $NTLA $VRTX $VTYX https://t.co/HsvywOztkC https://t.co/im5wWXPsjd

          CNBC

          Cramer's lightning round: I would hold onto Biomarin Pharmaceutical

            SeekingAlpha

            Watch BioMarin Pharmaceutical after Turning Point sale to Bristol Myers - analyst

              @eWhispers
              eWhispers

              #earnings after the close https://t.co/lObOE0dgsr $F $TDOC $TWLO $NOW $EBAY $ALGN $UPWK $LC $SU $AR $XLNX $NLY $IRBT $KLAC $SNBR $MKSI $URI $CCS $YUMC $EW $SIMO $VICI $BMRN $CTSH $BOOT $ORLY $NTGR $AEM $UCTT $AFL $MXL $ALSN $RJF $EQT $NOVA $NOA $TROX $SAVE $CACI $EXR $ALGT https://t.co/PFBn7b2UNd

              Analysts Recommendations

              Bullish

              Buy

              Strong Buy

              Buy

              Hold

              Sell

              Strong Sell

              Day Range

              55.05USD
              56.09USD

              52 Week Range

              49.26USD
              70.98USD

              Market Cap

              10.83BUSD

              lock-imagelock-image

              Get Full Access with Profit PRO

              See which Billionaires own this investment

              About

              General Information

              Type

              Common Stock

              Exchange

              NASDAQ

              Currency Code

              USD

              Currency Name

              US Dollar

              Country Name

              USA

              Country ISO

              US

              ISIN

              US09061G1013

              CUSIP

              09061G101

              Sector

              Healthcare

              Industry

              Biotechnology

              Fiscal Year End

              December

              IPO date

              -

              Updated At

              -

              Highlights

              PE Ratio

              150.68

              PEG Ratio

              0.33

              Book Value

              32.66

              Dividend Share

              -

              Dividend Yield

              -

              Earnings Share

              0.37

              Wall Street Target Price

              91.56

              EPS Estimate Current Year

              3.51

              EPS Estimate Next Year

              6.39

              EPS Estimate Current Quarter

              0.9542

              EPS Estimate Next Quarter

              1.4903

              Most Recent Quarter

              -

              Profitability

              Revenue TTM

              3,406,614,016

              Gross Profit TTM

              1,736,295,040

              EBITDA

              645,318,976

              Profit Margin

              2.14%

              Return On Assets TTM

              3.26%

              Return On Equity TTM

              1.18%

              Revenue Per Share TTM

              17.692

              Qtly Revenue Growth YOY

              19.90%

              Diluted Eps TTM

              0.37

              Qtly Earnings Growth YOY

              -81.30%

              Valuation

              Trailing PE

              150.68

              Forward PE

              8

              Price Sales TTM

              3.1679

              Price Book MRQ

              1.7132

              Enterprise Value Revenue

              4

              Enterprise Value EBITDA

              36

              Peers analysis

              • Moderna Inc
                MRNAModerna Inc

                206.53

                4.47%
              • UCB SA
                UCBJFUCB SA

                305.59

                4.16%
              • argenx NV ADR
                ARGXargenx NV ADR

                882.35

                1.82%
              • Regeneron Pharmaceuticals Inc
                REGNRegeneron Pharmaceuticals Inc

                816.10

                1.09%
              • Vertex Pharmaceuticals Inc
                VRTXVertex Pharmaceuticals Inc

                521.03

                0.74%
              • argenx SE
                ARGNFargenx SE

                790.15

                0.00%
              • CSL Limited
                CMXHFCSL Limited

                136.90

                0.00%
              • Be
                ONCBeiGene, Ltd.

                366.06

                -1.28%
              • CSL Ltd
                CSLLYCSL Ltd

                34.16

                -1.27%
              • UCB SA ADR
                UCBJYUCB SA ADR

                151.18

                -0.48%

              FAQs

              What is Biomarin Pharmaceutical stock price today?

              What is Biomarin Pharmaceutical stock ticker?

              Is BMRN stock price going up?

              What is the analyst recommendation for BMRN?

              What is BMRN market cap?

              Does BMRN release financial reports?

              When is BMRN next earnings date?

              What were BMRN Earnings for the last quarter?

              What was BMRN Revenue for the last quarter?

              What was BMRN Net Income for the last quarter?

              Does BMRN pay dividends?

              How many employees does BMRN have?

              What is BMRN EBITDA?

              How to buy BMRN stocks?

              Should I invest in BMRN stock?